BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 310 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $535,000 | +8.7% | 3,542 | +4.9% | 0.01% | 0.0% |
| Q2 2022 | $492,000 | +57.2% | 3,376 | +27.9% | 0.01% | +100.0% |
| Q1 2022 | $313,000 | -13.3% | 2,640 | +0.8% | 0.01% | -16.7% |
| Q4 2021 | $361,000 | -0.8% | 2,619 | +0.0% | 0.01% | -14.3% |
| Q3 2021 | $364,000 | +26.8% | 2,618 | -11.5% | 0.01% | +40.0% |
| Q2 2021 | $287,000 | – | 2,959 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 710,422 | $24,658,747 | 16.62% |
| Birchview Capital, LP | 7,365 | $255,639 | 0.24% |
| Itau Unibanco Holding S.A. | 88 | $3,054 | 0.00% |